Out of this careful analysis, we have settled on a strategy to focus the company's resources primarily on continuing to grow our biomanufacturing business, Avid Bioservices, while continuing to advance R&D efforts through smaller clinical trials and the development of new technologies that can be partnered in an early stage. With the goal of becoming cash flow positive over the next couple of years, this strategy will allow us to increase shareholder value in several ways.
NOW I realize if it were up to me - which clearly it is not - I'd ask management for a shareholder letter laying out BEYOND Avid expansion etc.,......the HOW, WHEN, WHY AND WHERE they PLAN to get BAVI, BBs to MARKET, or FURTHER monetize their new EXOSOME tech???
I find it a touch alarming that at this point a RS is even an option.
Should management wish me to continue to BUY shares......AVID expansion ALONE or the ABOCE is not going to sway me.
The company clearly has potential but come on.
Fear Uncertainty and Doubt FUD It Ain't Going To Work Here Anymore. Notice the lack of question mark.